Equities

Yield10 Bioscience Inc

YTEN:QBB

Yield10 Bioscience Inc

Actions
  • Price (USD)0.50
  • Today's Change-0.025 / -4.76%
  • Shares traded619.00
  • 1 Year change-90.39%
  • Beta1.5118
Data delayed at least 15 minutes, as of Nov 22 2024 19:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Yield10 Bioscience Inc share price to rise to 2.50 in the next year from the last price of 0.525.
High376.2%2.50
Med376.2%2.50
Low376.2%2.50

Earnings history & estimates in USD

On Aug 14, 2024, Yield10 Bioscience Inc reported 2nd quarter 2024 losses of -5.04 per share.
Average growth rate+22.70%
Yield10 Bioscience Inc reported annual 2023 losses of -43.68 per share on Apr 01, 2024.
Average growth rate+37.33%
More ▼

Revenue history & estimates in USD

Yield10 Bioscience, Inc. had 2nd quarter 2024 revenues of 450.00k. This bettered the 300.00k estimate of the one analyst covering the company. This was 650.00% above the prior year's 2nd quarter results.
Average growth rate+16.67%
Yield10 Bioscience, Inc. had revenues for the full year 2023 of 60.00k. This was 86.67% below the prior year's results.
Average growth rate-34.35%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.